Centers | ||
|
|
|
test | Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Therapeutic Accelerator Program (TAP) |
sfgd |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
Test |
Partnerships |
Events |
Jobs |
Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all Eisiai Partners with Johns Hopkins Brain Science InstituteEisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai... View all CWHM/OWH Childhood DiarrheaCWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5. Under the agreement, CWHM... View all |
No EVENTS for listing |
No Job Posts |
